Overview

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
A Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
Phase:
Phase 1
Details
Lead Sponsor:
Ziopharm